Common research protocols pair CJC-1295 (no DAC) with ipamorelin, dosed before sleep or fasted, but no protocol is FDA/EMA approved

People taking GLP-1 medications may experience a range of positive effects: Lower blood sugar levels, leading to improved diabetes control Promote weight loss, which can improve overall health and lower the risk of related medical problems Lower the risk of heart attacks, strokes, and kidney disease in people with diabetes or those at high cardiovascular risk Improve liver health in people with metabolic dysfunction-associated steatotic liver disease (MASLD) Help lower blood pressure and cholesterol, supporting overall heart health Reduce appetite and food cravings, making healthy eating patterns easier to maintain Less likely than some other diabetes medicines to cause low blood sugar or unwanted weight gain Can provide meaningful and lasting results for people who have struggled to lose weight with lifestyle changes alone Are there specific lifestyle changes that work best with these medications

The purpose of this review was to provide a brief account of these developments and to discuss the possible mechanisms involved
Raghu G, Chen S-Y, Yeh W-S, Maroni B, Li Q, Lee Y-C, et al
[15] [16] UK prescribing information includes this as a warning/precaution rather than a contraindication, advising caution in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
CJC 1295 + Ipamorelin is the combination of two peptides that work together to stimulate the pituitary gland to naturally produce more Human Growth Hormone Secretagogue so they act on two different families of receptors to increase your bodys own HGH